BiotechTube
Home/Opko Health/Jane H. Hsiao, Ph.D., MBA
JH

Jane H. Hsiao, Ph.D., MBA

Vice Chairman and Chief Technical Officer

Opko Health

Therapeutic Areas

EndocrinologyNephrologyOncologyInfectious Diseases

Opko Health Pipeline

DrugIndicationPhase
NGENLA™ (somatrogon)Pediatric Growth Hormone DeficiencyMarket
RAYALDEE® (calcifediol)Secondary Hyperparathyroidism in CKDMarket
MDX2004Advanced CancersPhase 1
Multispecific Antibodies (with Regeneron)Select Therapeutic IndicationsResearch
Oral Long-Acting PTH TabletHypoparathyroidismPreclinical
Nanoparticle VaccinesInfectious DiseasesResearch

Leadership Team at Opko Health

PF
Phillip Frost, M.D.
Chairman and Chief Executive Officer
SD
Steven D. Rubin
Executive Vice President and Chief Financial Officer
EA
Elias A. Zerhouni, M.D.
Scientific Advisor (Former Director, NIH)
View full Opko Health profile